Balyasny Asset Management L.P. Raises Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Balyasny Asset Management L.P. lifted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 338.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 168,082 shares of the company’s stock after purchasing an additional 129,708 shares during the quarter. Balyasny Asset Management L.P. owned 0.10% of Option Care Health worth $3,900,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of OPCH. BNP Paribas Financial Markets purchased a new position in Option Care Health in the 4th quarter worth about $1,311,000. Ameriprise Financial Inc. grew its stake in shares of Option Care Health by 4.3% in the fourth quarter. Ameriprise Financial Inc. now owns 193,702 shares of the company’s stock worth $4,494,000 after acquiring an additional 7,922 shares during the period. Algert Global LLC raised its holdings in shares of Option Care Health by 29.3% during the fourth quarter. Algert Global LLC now owns 248,142 shares of the company’s stock valued at $5,757,000 after purchasing an additional 56,235 shares during the last quarter. Alyeska Investment Group L.P. lifted its position in Option Care Health by 159.0% during the fourth quarter. Alyeska Investment Group L.P. now owns 732,948 shares of the company’s stock valued at $17,004,000 after purchasing an additional 450,000 shares during the period. Finally, Freestone Grove Partners LP purchased a new stake in Option Care Health in the fourth quarter worth approximately $17,487,000. 98.05% of the stock is owned by institutional investors.

Insider Buying and Selling at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. JMP Securities restated a “market outperform” rating and set a $36.00 price target on shares of Option Care Health in a research note on Tuesday, April 22nd. Barrington Research restated an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 30th. UBS Group raised shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, JPMorgan Chase & Co. upped their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research note on Thursday, March 6th. One research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $35.50.

Option Care Health Stock Up 0.4 %

OPCH opened at $31.84 on Friday. The stock has a market cap of $5.21 billion, a price-to-earnings ratio of 26.76, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm’s fifty day moving average is $33.24 and its 200 day moving average is $28.89. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. During the same period in the previous year, the business earned $0.26 earnings per share. The business’s revenue was up 16.3% on a year-over-year basis. On average, sell-side analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.